Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients
4.6 (402) · $ 12.50 · In stock
Pruritus related to trastuzumab and pertuzumab in HER2 + breast
Frontiers Pyrotinib in the Treatment of Women With HER2-Positive
125409orig1s113 PDF, PDF, Pharmaceutical Sciences
Pruritus related to trastuzumab and pertuzumab in HER2 + breast
HER2-Positive Metastatic Breast Cancer Patients Receiving
Combination of everolimus with trastuzumab plus paclitaxel as
Pertuzumab, trastuzumab, and docetaxel for HER2-positive
Targeting HER2 in Breast Cancer: Latest Developments on Treatment
Association between pertuzumab-associated diarrhoea and rash and
Real World Evidence of Neoadjuvant Docetaxel/Carboplatin
Skin/nail infections with the addition of pertuzumab to
TCHP-Docetaxel Carboplatin Trastuzumab Pertuzumab Neoadjuvant
